Celltrion Allies With 180 Life Sciences On Repurposing Biosimilars

Strikes Deal To Supply Anti-TNF Products For Trials In Novel Indications

 
• By Dave Wallace

Celltrion has struck a deal with 180 Life Sciences to supply anti-TNF products to support the company’s work in pursuing new indications for off-patent biologics.

Repurpose dictionary highlight
Celltrion and 180 Life Sciences are collaborating on repurposing biosimilars • Source: Shutterstock

More from Deals

More from Business